1. Home
  2. INN vs ESPR Comparison

INN vs ESPR Comparison

Compare INN & ESPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

INN

Summit Hotel Properties Inc.

HOLD

Current Price

$6.79

Market Cap

766.1M

Sector

Real Estate

ML Signal

HOLD

ESPR

Esperion Therapeutics Inc.

HOLD

Current Price

$3.16

Market Cap

816.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
INN
ESPR
Founded
N/A
2008
Country
United States
United States
Employees
78
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
766.1M
816.9M
IPO Year
N/A
2013

Fundamental Metrics

Financial Performance
Metric
INN
ESPR
Price
$6.79
$3.16
Analyst Decision
Sell
Strong Buy
Analyst Count
2
4
Target Price
$4.50
$8.75
AVG Volume (30 Days)
2.0M
8.9M
Earning Date
04-30-2026
05-07-2026
Dividend Yield
6.41%
N/A
EPS Growth
N/A
60.71
EPS
N/A
N/A
Revenue
N/A
$403,135,000.00
Revenue This Year
$2.00
N/A
Revenue Next Year
$1.96
$12.81
P/E Ratio
N/A
N/A
Revenue Growth
N/A
21.31
52 Week Low
$3.98
$1.10
52 Week High
$7.15
$4.18

Technical Indicators

Market Signals
Indicator
INN
ESPR
Relative Strength Index (RSI) 63.29 64.86
Support Level $4.15 $3.13
Resistance Level N/A $3.18
Average True Range (ATR) 0.24 0.02
MACD -0.01 -0.01
Stochastic Oscillator 69.00 75.00

Price Performance

Historical Comparison
INN
ESPR

About INN Summit Hotel Properties Inc.

Summit Hotel Properties Inc is a U.S.-based hotel investment company focusing on select-service hotels in the upscale and upper-midscale properties in the U.S. Substantially all of Summit's assets are held and operated by its Operating Partnership, Summit Hotel OP, LP, in which the company holds general and limited partnership interests. The firm has one segment in activities related to investing in real estate. Summit's revenue streams include Room and Other hotel operations revenue. Room comprises the majority of total revenues. The company's hotels are located in various markets, such as corporate offices, retail centers, airports, state capitols, convention centers, and leisure attractions. Summit's hotels operate under brands, including Marriott, Hilton, Hyatt, and Holiday Inn.

About ESPR Esperion Therapeutics Inc.

Esperion Therapeutics Inc is a commercial-stage biopharmaceutical company currently focused on bringing new medicines to patients that address unmet medical needs. It has developed and is commercializing U.S. Food and Drug Administration, or FDA, approved oral, once-daily, non-statin medicines for patients who are at risk for cardiovascular disease (or CVD and are struggling with elevated low-density lipoprotein cholesterol, or LDL-C. The Company views its operations and manages its business in one operating segment, which is the business of researching, developing, and commercializing therapies for the treatment of patients with elevated LDL-C. The company depends almost entirely on the success of two products, the bempedoic acid tablet and the bempedoic acid/ezetimibe combination tablet.

Share on Social Networks: